Evidence map›Paper›PMID 30526642›Full record

ArticleBMC research notes2018

A prospective study on dual time

Mike Allan Mortensen, Mie Holm Vilstrup, Mads Hvid Poulsen, Oke Gerke, Poul Flemming Høilund-Carlsen, Lars Lund

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Global disease score (GDS) is the name of the game!European journal of nuclear medicine and molecular imaging · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mike Allan MortensenDepartment of Urology, Odense University Hospital, Odense, Denmark. Mike.allan.mortensen@rsyd.dk.ORCID http://orcid.org/0000-0002-7065-9623
Mie Holm VilstrupDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Mads Hvid PoulsenDepartment of Urology, Odense University Hospital, Odense, Denmark.
Oke GerkeDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Poul Flemming Høilund-CarlsenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Lars LundDepartment of Urology, Odense University Hospital, Odense, Denmark.
Odense University Hospital · DKUniversity of Southern Denmark · DK

Funding

Kræftens Bekæmpelse A8400
6 · The paper itself

Abstract

objectiveThis proof of concept study investigated whether dual time point FDG-PET/CT with image acquisition after 1 and 3 h could be useful in preoperative staging of patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for high-risk prostate cancer.

resultsTwenty patients with high-risk prostate cancer underwent dual time point FDG-PET/CT before undergoing surgery. Histologically confirmed lymph node metastases were found in 9/20 (45%). A median of 19 (range 10-41; n = 434) lymph nodes were removed per patient. Pelvic lymph nodes with detectable FDG uptake were seen in two patients only, but the FDG-avid lesion on PET did not correspond with pathological findings in either patient. We found a significant increase in maximal standardized uptake value of the prostate of around 30% between early and late imaging. We found no correlation between clinical findings after radical prostatectomy and PET measurements.

Indexed as

Positron Emission Tomography Computed TomographyAgedFluorodeoxyglucose F18HumansMaleMiddle AgedPostoperative CareProspective StudiesProstatic NeoplasmsRisk FactorsTime FactorsFluorodeoxyglucose F18Diagnostic imagingFluorodeoxyglucosePositron emission tomographyProstatic neoplasms

Identifiers

PMID30526642
PMCPMC6286604
OpenAlexW2903606127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.